Fig. 2. Bivariate distribution of pre- and posttreatment HSV-2 IgG antibody titer levels and SPS guidance (
) change scores.
Fig. 2. Bivariate distribution of pre- and posttreatment HSV-2 IgG antibody titer levels and SPS guidance () change scores.